J
Joydeep Ghosh
Researcher at University of Texas at Austin
Publications - 513
Citations - 29870
Joydeep Ghosh is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Cluster analysis & Artificial neural network. The author has an hindex of 60, co-authored 474 publications receiving 26979 citations. Previous affiliations of Joydeep Ghosh include Los Angeles Mission College & National University of Singapore.
Papers
More filters
Proceedings ArticleDOI
Non-parametric Discovery of Topics and Communities in Distributed and Streaming Environments
Dean Teffer,Joydeep Ghosh +1 more
TL;DR: This work proposes a comprehensive and flexible approach to distributed and dynamic inference of Bayesian count factorization models, focusing on a recently introduced nonparametric, joint topic-community factorization model called Joint Gamma Process Poisson Factorization (JGPPF).
Journal ArticleDOI
Midbrain infarction in inherited protein S deficiency: a rare association.
TL;DR: In this article, a 30-year-old woman with sudden onset right-sided ptosis and ophthalmoplegia was admitted to a hospital with mild ischaemic stroke.
Journal ArticleDOI
EP216/#881 Safety and tolerability of olaparib in Indian patients with ovarian cancer: the prospective, single-arm, phase 4 soli trial
Joydeep Ghosh,Chandan Krushna Das,Ajay Gogia,G. Biswas,Chirag S. Desai,Sajjan Rajpurohit,Prashant Mehta,Keechilat Pavithran,Chanchal Goswami,Krishnakumar Rathnam,Sewanti Limaye,Vineet Talwar,Ajay K. Singh,Amit Dutta,Rohit Kodagali,Sudeep Gupta +15 more
TL;DR: In this paper , a prospective, single-arm, multicentre, phase 4 study in India (ClinicalTrials.gov Identifier: NCT04330040), eligible females (≥18 years) with PSR OC, in complete response (CR) or partial response (PR) to preceding platinum-based chemotherapy, received olaparib (300 mg BD) for 182 days or until its discontinuation.
Journal ArticleDOI
How I Treat Advanced Head Neck Cancer
TL;DR: The cost of modern therapies like cetuximab and IOs are beyond the reach of most people from India and the treatment of any cancer including metastatic HNSCC has to be tailored based on the financial affordability of the patients.
Journal ArticleDOI
64P Clinical profile and treatment outcome of patients with non-metastatic colon cancer: A single institutional study from India
J. Ganguly,N. Mukherjee,K Ray,Shamash Mandal,Archya Dasgupta,Mohandas K. Mallath,Tanuj Chawla,Meredith Ray,Amrit Pipara,Bivas Biswas,S Roy,Joydeep Ghosh +11 more
TL;DR: In this paper , a real-world study of the clinical profile and treatment patterns and outcomes of patients with nonmetastatic colon cancer from India is presented, where the authors report their experience in this patient population.